Table of Content

Table of Contents

Global Human Blood Plasma Fractionation Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Human Blood Plasma Fractionation Market by Value
2.2.1 Global Human Blood Plasma Fractionation Revenue by Type
2.2.2 Global Human Blood Plasma Fractionation Market by Value (%)
2.3 Global Human Blood Plasma Fractionation Market by Production
2.3.1 Global Human Blood Plasma Fractionation Production by Type
2.3.2 Global Human Blood Plasma Fractionation Market by Production (%)

3. The Major Driver of Human Blood Plasma Fractionation Industry
3.1 Historical & Forecast Global Human Blood Plasma Fractionation Demand
3.2 Largest Application for Human Blood Plasma Fractionation (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Human Blood Plasma Fractionation Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Human Blood Plasma Fractionation Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Human Blood Plasma Fractionation Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Human Blood Plasma Fractionation Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Human Blood Plasma Fractionation Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Human Blood Plasma Fractionation Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Human Blood Plasma Fractionation Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Human Blood Plasma Fractionation Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Human Blood Plasma Fractionation Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Human Blood Plasma Fractionation Average Price Trend
12.1 Market Price for Each Type of Human Blood Plasma Fractionation in US (2018-2022)
12.2 Market Price for Each Type of Human Blood Plasma Fractionation in Europe (2018-2022)
12.3 Market Price for Each Type of Human Blood Plasma Fractionation in China (2018-2022)
12.4 Market Price for Each Type of Human Blood Plasma Fractionation in Japan (2018-2022)
12.5 Market Price for Each Type of Human Blood Plasma Fractionation in India (2018-2022)
12.6 Market Price for Each Type of Human Blood Plasma Fractionation in Korea (2018-2022)
12.7 Market Price for Each Type of Human Blood Plasma Fractionation in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Human Blood Plasma Fractionation Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Human Blood Plasma Fractionation

14. Human Blood Plasma Fractionation Competitive Landscape
14.1 Takeda
14.1.1 Takeda Company Profiles
14.1.2 Takeda Product Introduction
14.1.3 Takeda Human Blood Plasma Fractionation Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 CSL
14.2.1 CSL Company Profiles
14.2.2 CSL Product Introduction
14.2.3 CSL Human Blood Plasma Fractionation Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Grifols
14.3.1 Grifols Company Profiles
14.3.2 Grifols Product Introduction
14.3.3 Grifols Human Blood Plasma Fractionation Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Octapharma
14.4.1 Octapharma Company Profiles
14.4.2 Octapharma Product Introduction
14.4.3 Octapharma Human Blood Plasma Fractionation Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Kedrion
14.5.1 Kedrion Company Profiles
14.5.2 Kedrion Product Introduction
14.5.3 Kedrion Human Blood Plasma Fractionation Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 LFB Group
14.6.1 LFB Group Company Profiles
14.6.2 LFB Group Product Introduction
14.6.3 LFB Group Human Blood Plasma Fractionation Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Biotest
14.7.1 Biotest Company Profiles
14.7.2 Biotest Product Introduction
14.7.3 Biotest Human Blood Plasma Fractionation Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 BPL
14.8.1 BPL Company Profiles
14.8.2 BPL Product Introduction
14.8.3 BPL Human Blood Plasma Fractionation Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 RAAS
14.9.1 RAAS Company Profiles
14.9.2 RAAS Product Introduction
14.9.3 RAAS Human Blood Plasma Fractionation Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 CBPO
14.10.1 CBPO Company Profiles
14.10.2 CBPO Product Introduction
14.10.3 CBPO Human Blood Plasma Fractionation Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Hualan Bio
14.12 Tiantan Bio
14.13 Shuanglin Bio
14.14 Boya Bio
14.15 Yuanda Shuyang
14.16 Weiguang Bio
14.17 Nanyue Bio
14.18 KM Biologics
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Human Blood Plasma Fractionation Industry (Volume)
Figure 2. Human Blood Plasma Fractionation Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Human Blood Plasma Fractionation Revenue in 2022
Figure 5. US Human Blood Plasma Fractionation Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Human Blood Plasma Fractionation Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Human Blood Plasma Fractionation Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Human Blood Plasma Fractionation Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Human Blood Plasma Fractionation Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Human Blood Plasma Fractionation Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Human Blood Plasma Fractionation Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Human Blood Plasma Fractionation Revenue, by Type (Million USD) (2018-2028)
Table 4. Human Blood Plasma Fractionation Production, by Type (K Unit) (2018-2028)
Table 5. Human Blood Plasma Fractionation Demand (K Unit) by Application (2018-2028)
Table 6. Human Blood Plasma Fractionation Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Human Blood Plasma Fractionation Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Human Blood Plasma Fractionation Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Human Blood Plasma Fractionation Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Human Blood Plasma Fractionation Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Human Blood Plasma Fractionation Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Human Blood Plasma Fractionation Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Human Blood Plasma Fractionation Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Human Blood Plasma Fractionation Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Human Blood Plasma Fractionation in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Human Blood Plasma Fractionation in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Human Blood Plasma Fractionation in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Human Blood Plasma Fractionation in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Human Blood Plasma Fractionation in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Human Blood Plasma Fractionation in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Human Blood Plasma Fractionation in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Takeda Profiles
Table 61. Takeda Human Blood Plasma Fractionation Product Introduction
Table 62. Takeda Human Blood Plasma Fractionation Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Takeda Strategic initiatives
Table 64. CSL Profiles
Table 65. CSL Human Blood Plasma Fractionation Product Introduction
Table 66. CSL Human Blood Plasma Fractionation Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. CSL Strategic initiatives
Table 68. Grifols Profiles
Table 69. Grifols Human Blood Plasma Fractionation Product Introduction
Table 70. Grifols Human Blood Plasma Fractionation Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Grifols Strategic initiatives
Table 72. Octapharma Profiles
Table 73. Octapharma Human Blood Plasma Fractionation Product Introduction
Table 74. Octapharma Human Blood Plasma Fractionation Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Octapharma Strategic initiatives
Table 76. Kedrion Profiles
Table 77. Kedrion Human Blood Plasma Fractionation Product Introduction
Table 78. Kedrion Human Blood Plasma Fractionation Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Kedrion Strategic initiatives
Table 80. LFB Group Profiles
Table 81. LFB Group Human Blood Plasma Fractionation Product Introduction
Table 82. LFB Group Human Blood Plasma Fractionation Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. LFB Group Strategic initiatives
Table 84. Biotest Profiles
Table 85. Biotest Human Blood Plasma Fractionation Product Introduction
Table 86. Biotest Human Blood Plasma Fractionation Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Biotest Strategic initiatives
Table 88. BPL Profiles
Table 89. BPL Human Blood Plasma Fractionation Product Introduction
Table 90. BPL Human Blood Plasma Fractionation Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. BPL Strategic initiatives
Table 92. RAAS Profiles
Table 93. RAAS Human Blood Plasma Fractionation Product Introduction
Table 94. RAAS Human Blood Plasma Fractionation Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. RAAS Strategic initiatives
Table 97. CBPO Profiles
Table 98. CBPO Human Blood Plasma Fractionation Product Introduction
Table 99. CBPO Human Blood Plasma Fractionation Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. CBPO Strategic initiatives
Table 101. Hualan Bio Profiles
Table 102. Hualan Bio Human Blood Plasma Fractionation Product Introduction
Table 103. Hualan Bio Human Blood Plasma Fractionation Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. Hualan Bio Strategic initiatives
Table 105. Tiantan Bio Profiles
Table 106. Tiantan Bio Human Blood Plasma Fractionation Product Introduction
Table 107. Tiantan Bio Human Blood Plasma Fractionation Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. Tiantan Bio Strategic initiatives
Table 109. Shuanglin Bio Profiles
Table 110. Shuanglin Bio Human Blood Plasma Fractionation Product Introduction
Table 111. Shuanglin Bio Human Blood Plasma Fractionation Production (Unit), Revenue (Million USD) (2018-2022)
Table 112. Shuanglin Bio Strategic initiatives
Table 113. Boya Bio Profiles
Table 114. Boya Bio Human Blood Plasma Fractionation Product Introduction
Table 115. Boya Bio Human Blood Plasma Fractionation Production (Unit), Revenue (Million USD) (2018-2022)
Table 116. Boya Bio Strategic initiatives
Table 117. Yuanda Shuyang Profiles
Table 118. Yuanda Shuyang Human Blood Plasma Fractionation Product Introduction
Table 119. Yuanda Shuyang Human Blood Plasma Fractionation Production (Unit), Revenue (Million USD) (2018-2022)
Table 120. Yuanda Shuyang Strategic initiatives
Table 121. Weiguang Bio Profiles
Table 122. Weiguang Bio Human Blood Plasma Fractionation Product Introduction
Table 123. Weiguang Bio Human Blood Plasma Fractionation Production (Unit), Revenue (Million USD) (2018-2022)
Table 124. Weiguang Bio Strategic initiatives
Table 125. Nanyue Bio Profiles
Table 126. Nanyue Bio Human Blood Plasma Fractionation Product Introduction
Table 127. Nanyue Bio Human Blood Plasma Fractionation Production (Unit), Revenue (Million USD) (2018-2022)
Table 128. Nanyue Bio Strategic initiatives
Table 129. KM Biologics Profiles
Table 130. KM Biologics Human Blood Plasma Fractionation Product Introduction
Table 131. KM Biologics Human Blood Plasma Fractionation Production (Unit), Revenue (Million USD) (2018-2022)
Table 132. KM Biologics Strategic initiatives